Literature DB >> 3264304

T cell recognition of bovine ribonuclease. Self/non-self discrimination at the level of binding to the I-Ak molecule.

R G Lorenz1, A N Tyler, P M Allen.   

Abstract

Bovine RNase A specific T-cell hybridomas were generated to study the recognition of foreign Ag by T lymphocytes. One hybrid, TS12, was shown to recognize RNase in association with I-Ak. This hybridoma required bovine RNase to be processed before recognition. The immunogenic determinant on the RNase molecule recognized by TS12 was localized to the tryptic fragment RNase(40-61). All of the stimulatory ability of this determinant was shown to be contained within the synthetic 14mer RNase(43-56). When this segment of bovine RNase was compared with the self murine sequence, only one amino acid difference was found, a substitution of a proline residue at position 50 for a serine residue. This substitution completely abolishes binding to the I-Ak molecule, as shown by both functional and direct binding assays. This finding shows that self/non-self discrimination not only occurs at the level of the T cell, but also can be caused by an inability of the self peptide to associate with a class II molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264304

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.

Authors:  C V Harding; R W Roof; P M Allen; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Authors:  Rakesh H Basavalingappa; Rajkumar Arumugam; Ninaad Lasrado; Bharathi Yalaka; Chandirasegaran Massilamany; Arunakumar Gangaplara; Jean-Jack Riethoven; Shi-Hua Xiang; David Steffen; Jay Reddy
Journal:  Mol Immunol       Date:  2020-06-29       Impact factor: 4.407

3.  Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules.

Authors:  R D Hockett; J R Cook; K Findlay; C V Harding
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

Review 4.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas.

Authors:  Bharathi Krishnan; Chandirasegaran Massilamany; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Charles Kuszynski; Barbara Switzer; Daniel A Peterson; Jay Reddy
Journal:  J Immunol Methods       Date:  2015-08-09       Impact factor: 2.303

6.  Delineation of antigen contact residues on an MHC class II molecule.

Authors:  J Peccoud; P Dellabona; P Allen; C Benoist; D Mathis
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

7.  Epitope-specific enhancement of antigen presentation by invariant chain.

Authors:  F Momburg; S Fuchs; J Drexler; R Busch; M Post; G J Hämmerling; L Adorini
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

8.  Reconstruction of the immunogenic peptide RNase(43-56) by identification and transfer of the critical residues into an unrelated peptide backbone.

Authors:  R G Lorenz; A N Tyler; P M Allen
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

9.  Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart.

Authors:  D L Donermeyer; K W Beisel; P M Allen; S C Smith
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.

Authors:  J C Guéry; M Neagu; G Rodriguez-Tarduchy; L Adorini
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.